NYSE$WELL

Welltower Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Welltower's first quarter 2022 results were reported, demonstrating growth in key areas.

Welltower reported a solid first quarter in 2022, marked by normalized FFO exceeding guidance, significant growth in Seniors Housing Operating portfolio occupancy and same-store NOI, and substantial investment activity.

  • Net income attributable to common stockholders was reported at $0.14 per diluted share.
  • Normalized FFO attributable to common stockholders was reported at $0.82 per diluted share, surpassing the guidance midpoint.
  • Seniors Housing Operating portfolio average same-store occupancy increased by approximately 460 bps year-over-year to 78.0%.
  • Total portfolio same-store NOI grew by 8.9%, driven by an 18.4% increase in the SHO portfolio.

Headline financials

Total Revenue

$1.4B

Previous: $1.05B+32.7%
EPS (adj)

$0.82

Previous: $0.80+2.5%
Normalized FFO per diluted share

$368M

No prior period
Capital Expenditures

-$830M

Previous: -$671M-23.7%
Free Cash Flow

-$764M

Previous: -$599M-27.6%
Net Income

$65.8M

Previous: $72.2M-8.9%
Operating Income

$175M

Previous: $371M-52.9%
Gross Profit

$542M

Previous: $435M+24.7%
Cash & Equivalents

$301M

Previous: $2.13B-85.9%
Total Assets

$35.5B

Previous: $33B+7.5%
Stock-Based Comp

$7.45M

Previous: $5.58M+33.5%

Revenue & EPS history

Welltower · Revenue · Quarterly

$1.4B

Q1 2022+32.7%vs Q1 2021
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Welltower · $994M total across 1 segment · Q1 2022

  • Resident fees and services
    $994M+37.4%

Forward guidance

Welltower anticipates net income per share between $0.20 and $0.25 and normalized FFO per share between $0.82 and $0.87 for the second quarter of 2022.

Tailwinds

  • Expects average blended SSNOI growth of 8.0% to 10.0%.
  • Seniors Housing Operating SSNOI growth is projected at approximately 15.0% to 20.0%.
  • Seniors Housing Triple-net SSNOI growth is anticipated at approximately 7.0% to 8.0%.
  • Outpatient Medical SSNOI growth is expected to be approximately 2.0% to 3.0%.
  • Includes approximately $6 million of Provider Relief Funds expected to be received during the quarter.

Headwinds

  • The impact of the COVID-19 pandemic remains highly uncertain.
  • General and administrative expenses are anticipated to be approximately $35 million to $37 million.
  • Stock-based compensation expense is expected to be approximately $6 million.
  • Guidance includes only acquisitions closed or announced to date.
  • Guidance does not include any additional investments, dispositions, or capital transactions beyond those announced.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.7%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.0%

Avg return

30 days after

61%

43 / 70 earnings

Positive

+9.1%

Q3 2022

Best reaction

-12.9%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.0%+1.4%-3.9%
Q4 2025+3.5%+4.9%+3.5%
Q3 2025-1.6%-0.9%+12.9%
Q2 2025+0.6%+2.5%+4.5%
Q1 2025+1.6%+1.1%+2.7%
Q4 2024+2.2%+4.6%+3.1%
Q3 2024+5.5%+2.4%+7.0%
Q2 2024+2.2%+2.7%+10.3%
Q1 2024+1.0%+1.6%+6.7%
Q4 2023+6.6%+6.4%+4.7%
Q3 2023+2.8%+8.7%+8.4%
Q2 2023+4.4%+1.7%+2.3%
Q1 2023-0.9%+0.6%-4.7%
Q4 2022+3.0%+2.2%-9.2%
Q3 2022+9.1%+17.4%+6.6%
Q2 2022+2.1%+1.3%-6.4%
Q1 2022-0.1%+1.5%-4.4%
Q4 2021+5.3%+4.0%+15.5%
Q3 2021+2.1%+3.1%-2.9%
Q2 2021-0.6%-0.3%-2.0%
Q1 2021-0.5%+0.0%-2.2%
Q4 2020+2.7%+6.8%+16.1%
Q3 2020+1.1%+5.0%+19.5%
Q2 2020+5.9%+7.8%+14.7%
Q1 2020-12.9%-12.7%+27.8%
Q4 2019+3.3%+5.2%-39.6%
Q3 2019+1.7%+2.4%-2.4%
Q2 2019-0.3%+1.1%+6.7%
Q1 2019+2.6%+4.7%+10.6%
Q4 2018+0.2%+0.2%+0.6%
Q3 2018+0.1%-0.2%+8.3%
Q2 2018-4.1%-2.1%+2.5%
Q1 2018+4.7%+8.6%+12.6%
Q4 2017+0.8%-3.3%-3.6%
Q3 2017+1.1%+0.2%-2.7%
Q2 2017+0.8%-0.5%-1.2%
Q1 2017-0.2%+0.2%+5.6%
Q4 2016+2.9%+4.6%+4.1%
Q3 2016-2.1%-1.7%-6.9%
Q2 2016-2.7%-4.1%-4.0%
Q1 2016+5.8%
Q4 2015+4.7%
Q3 2015-1.6%
Q2 2015-1.8%
Q1 2015-1.0%
Q4 2014+3.2%
Q3 2014+0.4%
Q2 2014+1.7%
Q1 2014+1.2%
Q4 2013-0.7%
Q3 2013-2.8%
Q2 2013-0.9%
Q1 2013-1.3%
Q4 2012-2.0%
Q3 2012+1.5%
Q2 2012-3.3%
Q1 2012-1.2%
Q4 2011-2.6%
Q3 2011-4.3%
Q2 2011+5.6%
Q1 2010+0.2%
Q1 2011-0.2%
Q4 2009+1.7%
Q4 2010+1.7%
Q1 2009+1.7%
Q4 2008+1.7%
Q3 2009-4.4%
Q3 2010-4.4%
Q2 2010+0.2%
Q2 2009+0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro